Hiroshi Kitamura

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study.

R. Saito, N. Nishiyama, Fumihiko Urabe, 2024, International journal of urology : official journal of the Japanese Urological Association.

Association of increased age with decreased response to intravesical instillation of Bacille Calmette-Guérin in patients with high-risk non-muscle invasive bladder cancer: Retrospective multi-institute results from the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG.

H. Nishiyama, T. Habuchi, J. Inokuchi, 2022, Urology.

Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study

N. Hinata, M. Miyake, K. Numakura, 2023, Scientific reports.

Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost-a survey in Japan.

R. Machida, K. Sasaki, Takashi Matsumoto, 2024, Japanese journal of clinical oncology.

Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan

T. Abe, S. Naito, T. Hara, 2024, International journal of urology : official journal of the Japanese Urological Association.

The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy

J. Inokuchi, N. Nishiyama, T. Kojima, 2023, Japanese journal of clinical oncology.

Treatment patterns and prognosis in patients with Bacillus Calmette–Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis

J. Inokuchi, N. Nishiyama, T. Kojima, 2024, World journal of urology.

Validation of non‐muscle‐invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines

N. Nishiyama, T. Kojima, M. Miyake, 2023, BJUI compass.

Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories

R. Kanesvaran, L. Lee, Chi-Fai Ng, 2023, International journal of urology : official journal of the Japanese Urological Association.

Controversies in terminology associated with management of BCG‐unresponsive NMIBC in Asia‐Pacific

R. Kanesvaran, L. Lee, Chi-Fai Ng, 2023, International journal of urology : official journal of the Japanese Urological Association.

J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.

C. Kitagawa, N. Nishiyama, K. Fujimoto, 2024, International journal of urology : official journal of the Japanese Urological Association.